Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Carlson, Kristina  [Clear All Filters]
Journal Article
Mellqvist, U.-H., Gimsing, P., Hjertner, O., Lenhoff, S., Laane, E., Remes, K., Steingrimsdottir, H., Abildgaard, N., Ahlberg, L., Blimark, C., et al. (2013). Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase III trial.Blood.
Burt, R.K., Balabanov, R., Burman, J., Sharrack, B., Snowden, J.A., Oliveira, M.Carolina, Fagius, J., Rose, J., Nelson, F., Barreira, A.Antunes, et al. (2019). Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.Jama321, 165-174.
Raj, K., Eikema, D.-J., McLornan, D.P., Olavarria, E., Blok, H.-J., Bregante, S., Ciceri, F., Passweg, J., Ljungman, P., Schaap, N., et al. (2018). Family mismatched allogeneic stem cell transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of EBMT.Biol Blood Marrow Transplant.
Vaht, K., Göransson, M., Carlson, K., Isaksson, C., Lenhoff, S., Sandstedt, A., Uggla, B., Winiarski, J., Ljungman, P., Andersson, P.-O., et al. (2019). High graft-versus-host disease-free, relapse/rejection-free survival and similar outcome of related and unrelated allogeneic stem cell transplantation for aplastic anemia - a nationwide Swedish cohort study.Biol Blood Marrow Transplant.
Wålinder, G., Samuelsson, J., Näsman, P., Hansson, M., Juliusson, G., Forsberg, K., Svensson, R., Linder, O., Carlson, K., Kristinsson, S.Y., et al. (2019). Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry.Eur J Haematol.